Simultaneous and Direct Determination of Vancomycin and Cephalexin in Human Plasma by Using HPLC-DAD Coupled with Second-Order Calibration Algorithms by Hu, Le-Qian et al.
Hindawi Publishing Corporation
Journal of Analytical Methods in Chemistry
Volume 2012, Article ID 256963, 8 pages
doi:10.1155/2012/256963
Research Article
Simultaneous and Direct Determination of Vancomycinand
Cephalexinin Human Plasma by UsingHPLC-DAD Coupled with
Second-OrderCalibration Algorithms
Le-QianHu,Chun-LingYin,Ya-HuiDu,andZhi-PengZeng
School of Chemistry and Chemical Engineering, Henan University of Technology, Zhengzhou 450001, China
Correspondence should be addressed to Le-Qian Hu, leqianhu@yeah.net
Received 12 January 2012; Accepted 6 February 2012
Academic Editor: Josep Esteve-Romero
Copyright © 2012 Le-Qian Hu et al. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
A simple, rapid, and sensitive method for the simultaneous determination of vancomycin and cephalexin in human plasma was
developed by using HPLC-DAD with second-order calibration algorithms. Instead of a completely chromatographic separation,
mathematical separation was performed by using two trilinear decomposition algorithms, that is, PARAFAC-alternative least
squares (PARAFAC-ALSs) and self-weight-alternative-trilinear-decomposition- (SWATLD-) coupled high-performance liquid
chromatography with DAD detection. The average recoveries attained from PARAFAC-ALS and SWATLD with the factor number
of 4 (N = 4) were 101 ±5% and 102 ±4% for vancomycin, and 96 ±3% and 97 ±3% for cephalexininde in real human samples,
respectively. The statistical comparison between PARAFAC-ALS and SWATLD is demonstrated to be similar. The results indicated
that the combination of HPLC-DAD detection with second-order calibration algorithms is a powerful tool to quantify the analytes
of interest from overlapped chromatographic proﬁles for complex analysis of drugs in plasma.
1.Introduction
Vancomycin belongs to a group of antibiotics called glyco-
peptides. It is used for severe staphylococcal and streptococ-
cal infections in patients intolerant of β-lactam antibiotics,
inmethicillin-resistantstaphylococcalinfections,andagainst
gram-positive organisms with multiple resistances to antibi-
otics [1]. Vancomycin has also been reported to cause con-
centration-dependent renal toxicities, and therefore mo-
nitoring of plasma vancomycin concentration is essential
to obtain suﬃcient eﬃcacy and to prevent toxic side ef-
fects [2]. On the other hand, as a narrow spectrum antimic-
robial, vancomycin has led to considerable interest in ex-
ploring antimicrobial combination therapy. The presence
of signiﬁcant in vitro synergy (time-kill method) between
levoﬂoxacin and vancomycin against clinical isolates of pen-
icillin resistant pneumoniae was encouraging [3]. This case
demonstrates that high-dose levoﬂoxacin in combination
with vancomycin is well tolerated and appeared to be eﬃca-
cious in a patient with refractory multiresistant pneumococ-
cal pericarditis. Vancomycin plus cephalexin [1, 4–7]i s
also current standard therapy of skin and skin-structure
infections (CSSIs) caused by gram-positive bacteria. Chlo-
ramphenicol combining with vancomycin against vancomy-
cin-resistant enterococci (VRE) [8] is also considered.
Monitoringofvancomycinandcephalexinconcentration
in human plasma is essential for obtaining suﬃcient eﬃcacy
as well as preventing side eﬀects. Various chromatographic
methods have been developed for the determination of
vancomycin individual in plasma samples [2]. Those include
HPLC with UV detection [9–14], LC/MS [15–17], LC with
electrochemical detection [18], and micellar electrokinetic
capillary chromatography [19]. Furuta et al. [9]r e p o r t e d
the direct injection method of plasma sample using a semi-
permeable surface packing material column. Cass et al. [16]
reported an automated determination method by LC/MS
coupled with on line extraction. However, these methods are
relativelycomplicatedandinconvenient,andthepeakofvan-
comycin in the chromatogram is often not clearly separated
from plasma blank peaks. In this case, quantiﬁcation with
univariate calibration will become biased and inaccurate.
At the same time, simultaneous quantitative analysis of2 Journal of Analytical Methods in Chemistry
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Figure 1: The structures of vancomycin and cephalexin.
vancomycin and its combination therapy drug will make the
analysis more diﬃcult. However, by analyzing the HPLC-
DAD data of unresolved peaks incorporating chemometric
tools, it is possible to resolve those questions [20].
Ideally, each chromatographic peak corresponds to a
single compound for HPLC analysis in optimized separation
conditions. Generally,the retention factor(k) of thediﬀerent
analytes is between 1 and 20 allowing their complete sepa-
ration. A peak with k equal to 0 is a component that does
not interact with the stationary phase and elutes in the void
volume.Chromatographicseparationscanbecomeadiﬃcult
taskwhenthesamplesareenvironmentalandbiologicalones
w h i c hh a v eac o m p l e xm a t r i xe ﬀects. The chromatographic
peak of analyte maybe overlaps with the interferences or
the other analytes. Particularly, the chromatographic resolu-
tion generally becomes poorer and partially separated peaks
often occur when the speed of chromatographic analyses is
increased, for example, by using higher ﬂows, shorter col-
umns, and so forth. On the other hand, it will be time-con-
suming and material-costing when completely chromato-
graphic separation is carried out for the complex samples.
At this time, applying mathematical separation as a comple-
mentary of chromatographic separation [21, 22] for resolv-
ing overlapping peaks is very promising. In chemometrics,
three-way data analysis method can be used to resolve this
question [21]. For HPLC-DAD, DAD can record the UV-
Vis spectra at every retention time, and a matrix (elution
time × wavelength) is obtained for every sample analyzed. A
cube matrix can be obtained by detecting multiple samples
simultaneously. The spectra of the calibration samples are
measured at the diﬀerent retention times of the peak of
the analyte of interest and the retention times are selected
by analyzing either a pure standard or a sample with a
known added concentration of the analyte. The spectra of
the predicted samples are measured at the diﬀerent retention
times of the peak from the unknown sample. Then the con-
centration of the analyte of interest in the overlapping peaks
can be quantiﬁed by applying second-order calibration algo-
rithms to the cube matrix.
In this paper, simultaneous and direct quantitative anal-
ysisof vancomycinand cephalexininhumanplasma samples
by using HPLC-DAD coupled with second-order calibration
algorithms was developed. Figure 1 lists the structures of the
Vancomycinandcephalexin.Thecalibrationresultsobtained
with PARAFAC-ALS and self-weight alternative trilinear
decomposition (SWATLD) were compared. These methods
allow quantifying directly vancomycin and cephalexin con-
centrationincomplexhumansamplematriceswithoutbeing
inﬂuenced by the interference from the components. In the
followingpart,boldcapitalletterformatrices,boldlowercase
for vectors, and italics for scalars were used.
2. Theory
2.1. Trilinear Model for Second-Order Resolution. The math-
ematicalformulationofHPLC-DADforN componentssam-
ples can also be expressed as follows:
xijk =
N 
n=1
ainbjnckn +eijk

i = 1,...,I; j = 1,...,J; k = 1,...,K

,
(1)
where xijk is the intensity of the kth sample at ith chromato-
graphic retention time and at jth wavelength. N is the total
number of detectable components. ain, bjn,a n dckn are the
elements of the loading matrices A, B, and C,r e s p e c t i v e l y .
A and B are the spectra and chromatographic proﬁles
matrices for all N components, respectively. C denotes the
relative concentration matrix. These can be expressed as A =
(a1,a2,...,an), B = (b1,b2,...,bn), and C = (c1,c2,...,cn).
eijk is the element of the measurement error matrix which
contains the variation not captured by the model.Journal of Analytical Methods in Chemistry 3
In contrast with bilinearity, the previous equation can be
considered to be trilinearity. It can be viewed as an extension
of Beer’s law to second-order data [23]. This amounts to
assumingthatthemeasuredpeakisthesumoftheindividual
peaks of each analyte and that the proﬁle and the spectrum
of one analyte are proportional in all the samples. As a con-
sequence, the decomposition of a three-way data array built
with response matrices measured for a number of samples is
often unique, allowing chromatographic proﬁle and spectral
proﬁles, as well as relative concentrations of individual sam-
ple components to be extracted directly. Numbers of three-
way methods used to resolve multicomponent mixtures have
been proposed. They include the generalized rank annihila-
tion method (GRAM) [24], direct trilinear decomposition
(DTLD) [25], parallel factor analysis (PARAFAC) [26], alter-
nating trilinear decomposition (ATLD)[27],coupledvectors
resolution (COVER) [28], and self-weighted alternating
trilinear decomposition (SWATLD) [29], multivariate curve
resolution coupled to alternating least squares (MCR-ALSs)
[30]. Due to the possibility of making analytical determina-
tions even in the presence of nonmodelled interferents (this
is known as the second-order advantage) [31] and to identify
the analyte of interest, three-way algorithm is becoming
increasingly important in routine analysis. In the second-
order calibration algorithms that allow quantiﬁcation even
inthepresenceofnoncalibratedcomponents,thePARAFAC-
ALS and SWATLD methods [32–34]a r ep r o v e dt ob ev e r y
useful for chromatographic data.
2.2. PARAFAC-ALS. PARAFAC is a generalization of prin-
cipal component analysis (PCA) to higher orders. In
PARAFAC, each component is trilinear, in contrast with
bilinear PCA, where one score and one loading vector
are obtained for each component. Three loading vectors
(an,bn,cn) are therefore given for each PARAFAC compo-
nent. The PARAFAC model of a three-way array is found by
minimizing the sum of the squares of the residuals eijk.E a c h
PARAFAC component gives three loadings: one relates to
the chromatographic proﬁle (an), one relates to the spectral
proﬁle (bn), and one relates to the content of the samples
(cn). Hence one loading is given for each dimension in the
data. The algorithm used to solve the PARAFAC model is
alternating least squares [26]. ALS successively assumes the
loadings in two modes and then estimates the unknown set
of parameters of the last mode. The algorithm converges
iteratively until the relative change in ﬁtting between two
iterations is below a certain value (the default is 10−6). It
is initialized by either random values or values calculated
by a direct trilinear decomposition based on the generalized
eigenvalue problem. Constraining the PARAFAC solution
can sometimes be helpful in terms of the interpretability or
the stability of the model. The resolution of spectra used to
require the nonnegativity constraint since negative spectral
parameters do not make sense.
2.3. SWATLD. The PARAFAC algorithm is based on a
least-square minimization, whereas SWATLD uses a pro-
cedure known as alternating trilinear decomposition [29].
The underlying theories have been recently reviewed [35].
Comparing with the PARAFAC algorithm, the SWATLD
algorithm has the advantages of fast convergence and insen-
sitivitytotheexcessfactorsusedincalculations[23].Accord-
ing to some experience, it oﬀers better results than other
second-order algorithms. There is a more detailed explana-
tion of the algorithm in [29, 35].
All computer programs were written in the MATLAB
(MathWorks) programming environment, and all calcula-
tions were carried out on a personal computer (Pentium IV
processor).
3. Experimental
3.1. Reagents and Solutions. Vancomycin was purchased
from Sigma (St Louis, MO, USA). Cephalexin was purchased
from National Institute for the Control of Pharmaceutical
and Biological Products in Changsha. Ethyl acetate was
purchased from Sinochem Group ShangHai Corporation.
Experiment water is doubly distilled water. All other reagents
were of analytical grade. The stock solution was prepared
by dissolving the vancomycin and cephalexin in the doubly
distilledwater,respectively.Theyareallstoredinglassat4◦C.
3.2. Preparation of Human Plasma Samples. Human plasma
samples received from the center of blood in changsha
obtained from the healthy people were used to prepare
predicted samples. Six of 2mL samples of plasma were
combined with various concentrations of the vancomycin
and cephalexin stock solutions and ethyl acetate were added.
Thereafter, the mixture was shaken in a vortex for 30s and
centrifuged at 3500rpm for 5min, and the organic phase
was evaporated, respectively. Then, doubly distilled water
was added to these ﬂasks in order to obtain 10mL solution.
Table 1 displays the concentration of six synthetical plasma
samples. The plasma fraction was collected and stored at 4◦C
until analyzed.
3.3. HPLC Instrumentation and Conditions. Throughout the
analysis was carried out using an HPLC system (Agilent
Series 1100, Agilent Technologies, Palo Alto, CA, USA),
which consists of vacuum degasser, autosampler, and a
binary pump, equipped with a Zorbax Eclipse XDB-C8
analytical column (125 × 4.0mm; 5um). Theoretically, the
analytes of interest can be determined precisely by changing
the experimental conditions to achieve full resolution. This
involves spending time and resources, and there is no
guarantee that the separation will be complete. According to
our experiments, the completely separation of vancomycin
and cephalexin is diﬃcult to carry out. It is also noticed that
the chromatographic peak shape of vancomycin will become
wide when we try to separate vancomycin and cephalexin
by adjusting the mobile phase. This will make the last cali-
bration result inaccuracy. Therefore in our experiment, the
following chromatographic conditions are applied. Column
temperature was maintained at 30◦C. Mobile phases A and4 Journal of Analytical Methods in Chemistry
Table 1: Determination results of vancomycin and Cephalexin by HPLC-DAD using PARAFAC-ALS and SWATLD algorithm in human
plasma (N = 4).
Sample
Added SWATLD PARAFAC
Vanc Cepd Vanc Cepd Vanc Cepd
(mg/mL) (mg/mL) (mg/mL) (mg/mL) (mg/mL) (mg/mL)
11 15.15 15.27 14.25 14.71 14.02 14.57
12 20.20 20.36 20.58 20.52 20.06 20.49
13 30.30 10.18 30.64 9.99 30.39 10.02
14 20.20 30.54 21.52 29.46 21.50 29.27
15 25.25 25.45 25.24 23.68 24.81 23.71
16 20.20 15.27 21.25 14.39 21.45 14.25
11 94.1% 96.4% 92.5% 95.4%
12 101.9% 100.8% 99.3% 100.7%
13 101.1% 98.1% 100.3% 98.5%
14 106.6% 96.5% 106.5% 95.8%
15 99.9% 93.0% 98.2% 93.2%
16 105.2% 94.2% 106.2% 93.3%
MRa 102 ± 4% 97 ± 3% 101 ± 5% 96 ± 3%
RMSEPb 0.0081 0.0095 0.0089 0.0102
aMean recovery.
bRoot mean square error of prediction.
cVancomycin.
dCephalexin.
B were methanol and 0.1M disodium hydrogen phosphate
buﬀer (40/60v/v %), respectively. The ﬂow-rate used was
kept at 1.0mL/min in each study. The wavelength used
was 200.0nm to 380.0nm with an interval of 2.0nm. The
run time used was in the range of 0min∼5min (1/30min
intervals). The baseline eﬀect is compensated by subtracting
themeasurementmatrixofanaverageblankfromthesample
measurement.
Sixteen samples are divided into two sets; that is, the ﬁrst
ten samples are the calibrated sets (no human plasma) and
the remaining six are the predicted set. The human plas-
ma was only added to six predicted samples (drug-free
plasma).Aftereliminatingthenoninformationdataobtained
withHPLC-DAD,three-waydataarrays(250×50×10)were
treated by using the PARAFAC-ALS and SWATLD, respec-
tively.
4. Results andDiscussion
4.1. Number of Factors. T h ec h e m i c a lr a n ki sd e ﬁ n e da s
the number of signiﬁcant factors distinguishing from noise.
When using PARAFAC, an initial deﬁnition of the number
of factors to build the model is necessary. This choice is
of fundamental importance because all conclusions about
the deconvolution and quantitation results will be related
with this number of factors. The analytes in the mixture
are often unknown in practical analysis process. Therefore,
deciding the underlying species in the mixture is always the
keysteptofurtherqualitativeandquantitativeanalysis.Some
methods have been suggested to estimate the chemical rank
of the three-way data arrays. Bro and Kiers [36]s u g g e s t e d
obtaining the number of responsive components (N)b y
consideration of the internal parameter known as core
consistency diagnosis (CORCONDIA), which is a measure
of how well a given model is able to reproduce the so-
called Tucker core of a cube of data. The core consistency is
calculated as a function of a trial number of components. It
remains near a value of 100 when the number is less than or
equal to the optimum; for exceeding component numbers it
drops below 50%.
Unconstrained PARAFAC-ALS models of this HPLC-
DAD data were developed using one to ten components, and
the percentage of ﬁt is used as the initial approach to select
the number of factors. Figure 2(a) shows the value obtained
for the 16-sample cube when studying the human plasma
sample. As can be seen, the core consistency drops to a very
low value when using ﬁve components to model the cube,
suggesting that N = 4 is a sensible choice. It shows that the
human plasma introduces some interferences to the mixture
system.
On the other hand, anyone of these methods cannot
ensure to obtain the accurate result for a practical mixture
system. Two or more methods are often used to estimate the
appropriate component number of the mixture to conﬁrm
the result [19]. We also suggest a simple linear transform
incorporating Monte Carlo simulation approach (which
names LTMC) to determine the component number of the
three-way data arrays [37]. The newly proposed method
decides the chemical rank through performing a simple
linear transform procedure to the original cube matrix to
produce two subspaces by singular value decomposition: oneJournal of Analytical Methods in Chemistry 5
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Figure 2: The results of factor-determining of the HPLC-DAD data arrays by CORCONDIA (a) and LTMC (b).
of two subspaces is derived from the original three-way data
arrayitselfandtheotherisderivedfromanewthree-waydata
array produced by the linear transformation of the original
one. Projection technique incorporating the Monte Carlo
approach acts as distinguishing criterion to chose the appro-
priatecomponentofthemixture.Thismethodisalsousedin
this experiment. Figure 2(b) also shows the result calculated
by the LTMC. The projection residuals for the former four
factors are relatively small but a rapid increase for the later
factors.Becausetheﬁrstfourfactorsrepresenttherealfactors
spaces,thelaterfactorsrepresentthenoisespaces.Itindicates
that the trilinear data arrays request to be ﬁtted exactly with
four factors. This is coincident with the result obtained by
CORCONDIA.
4.2. PARAFAC-ALS and SWATLD Analysis. Once the appro-
priate component number is correctly determined, three-
way HPLC-DAD data for the sixteen samples were ana-
lyzed by PARAFAC-ALS and SWATLD, respectively. Speciﬁc
details on the implementation of PARAFAC and SWATLD
methods will be given as follows. Figures 3 and 4 show the
chromatographicproﬁleandUV-Visspectraproﬁleobtained
with SWATLD. The chromatography and spectra of pure
vancomycin and cephalexin were obtained by measuring the
pure vancomycin and cephalexin and decomposing them
by singular value decomposition (SVD). It is also shown in
Figures 3 and 4. We regarded these normalized proﬁles as
the spectra of the pure and used them as reference spectra to
evaluate the reliability of the models in the calibration. The
correlation coeﬃcients which calculate the pure spectrum
and the ones resolved by SWATLD all exceed 0.998 for the
each individual analyte in this paper. It shows that the
SWATLD is reliable to resolve the HPLC-DAD data. The
resultofthePARAFAC-ALSisnotgivenforitssamenesswith
SWATLD.
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Figure 3: Normalized chromatographic proﬁles were resolved by
the SWATLD in human plasma. Solid and dotted lines represent the
chromatographic proﬁles of vancomycin, cephalexin, and interfer-
ence. The medium dash denotes the actual vancomycin and cepha-
lexin.
Two means can be used to decide on the concentration of
the predicted samples (unknown sample). Type one adopts
the following:
 c = diag

A+Xun

BT
+	
. (2)
Here A and B denote the chromatographic proﬁle and
spectral proﬁle, and Xun denotes the data matrix which
comes from an unknown sample. It is noticeable that the
interference included in the unknown samples should be
contained in matrices A and B. Otherwise the result will
be inaccurate. This type is often used in BLLS and GRAM.6 Journal of Analytical Methods in Chemistry
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Figure 4: Normalized UV-Vis spectral proﬁles were resolved by the
SWATLD in human plasma. Solid and dotted lines represent the
UV-vis spectral proﬁles of vancomycin, cephalexin, and interfer-
ence. The medium dash denotes the actual vancomycin and cepha-
lexin.
In PARAFAC and SWATLD, type two is often applied; that
is, the calibration step and predicted step are synchronous
implemented.TherelativeconcentrationcKncanbeacquired
by running two algorithms with the other loading. The
unknown concentration  yun of the nth component can be
obtained by regressing it based on the known standard con-
centration y of the nth component:
k = y+ ×[c1n | c2n |···|cKn],
 yun =
cun
k
.
(3)
Here“+”denotesthepseudoinverse.cKndenotestheconcen-
tration of the nth component in the Kth sample.
The prediction results for the human plasma samples are
listed in Table 1. The accuracy of the models was calculated
by the root mean square error of prediction (RMSEP):
RMSEP =

  

m
i=1

yi −  yi
2
m
,( 4 )
where yi and  yi are the added and predicted concentrations
of the given vancomycin or cephalexin in the ith predic-
tion sample, and m is the number of prediction samples.
RMSEPwas0.81%forvancomycinand0.95%forcephalexin
with SWATLD and 0.89% for vancomycin and 1.02% for
cephalexin with PARAFAC-ALS. It can be found that the
root mean square error of prediction of two algorithms is
very coincident. The SWATLD is only a slight superior to the
PARAFAC-ALS.
These values can also be expressed in terms of recovery
(as the percentage ratio between the predicted and the
true concentration) so that they could be compared with
two algorithms (Table 1). The average recoveries for the
PARAFAC-ALS procedure are 101 ± 5% for vancomycin and
96 ± 3% for cephalexin. For SWATLD, the average recoveries
are 102 ± 4% for vancomycin and 97 ± 3% for cephalexin,
respectively. So, in all the cases, recoveries are around the
ideal 100% for both methods; it shows that the dispersion of
the results was lower for SWATLD than that for PARAFAC-
ALS. On the same time, the iterative numbers of SWATLD
are shorter than PARAFAC-ALS (SWATLD only requests 15
times but 478 times for PARAFAC-ALS) and insensitive for
the chemical rank of the mixture system. This is coincident
with the former application.
4.3. Figures of Merit. Alternative methodology needs to be
validated by comparison with the other established methods.
The most important process for comparison of analytical
methods is the determination of ﬁgures of merit (FOM),
such as sensitivity, selectivity, and limit of detection (LOD).
In multivariate calibration, the net analyte signal (NAS)
calculation [31] is strictly necessary for the FOM evaluation.
The NAS for multiway data is analogous to those for ﬁrst-
order procedures, which is deﬁned as the part of the signal
that relates uniquely to the analyte of interest. In this case,
as the data are bilinear, the NAS is the pure analyte data
obtained by PARAFAC [38]. The sensitivity is estimated as
the NAS at unit concentration, as shown in (5), and the
selectivity is the ratio between the sensitivity and the total
signal, as shown in (6):
SEN = k

ATA
−1
nn

BTB
−1
nn
−1/2
,( 5 )
SEL =

ATA
−1
nn

BTB
−1
nn
−1/2
,( 6 )
where A and B are the matrices which collect spectral and
chromatographic proﬁles for all N components, respectively.
n denotes the nth component in mixture system. k denotes
the regression coeﬃcient calculated as aforementioned. The
limit of detection (LOD) [38] is calculated as
LOD = 3.3s(o),( 7 )
where s(o) is the standard deviation from the concentration
estimated for three diﬀerent blank samples in the PARAFAC
and SWATLD models, respectively. The more details can be
found [38]. In second-order calibration, diﬀerent analytes
are not separated completely by chromatography as tradition
performance. Thus the linear range has not been studied
in this paper. The ﬁgures of merit of vancomycin and
cephalexin for PARAFAC-ALS and SWATLD are displayed
in Table 2. As can be observed, the ﬁgures of merit for both
PARAFAC-ALS and SWATLD are very similar and only the
sensitivityofSWATLDisgreaterthanthatofPARAFAC-ALS.
In terms of the ﬁgures of merit, cephalexin is more selective
than vancomycin as its spectra are the most diﬀerent in
shape (see Figures 2 and 3) from the others and therefore the
least correlated. This preliminary information suggests that
cephalexin will be predicted at lower concentrations (it is the
more sensitive). This is conﬁrmed with the LOD calculated.
5. Conclusion
Simultaneous and direct determination of vancomycin and
cephalexin in human plasma by coupling HPLC-DAD withJournal of Analytical Methods in Chemistry 7
Table 2: Analytical ﬁgure of merit.
SWALTD PARAFAC
Figure of merita Vancomycin Cephalexin Vancomycin Cephalexin
Sensitivity (SEN), ABS, mL/mg 1.009 1.920 0.8921 1.301
Selectivity (SEL) 0.105 0.235 0.102 0.238
LOD, mg/mL 0.32 0.047 0.12 0. 026
aABS is the absorption intensity (arbitrary units).
second-order calibration algorithms was developed in this
paper. This approach allows quantifying vancomycin and
cephalexin under the incompletely chromatographic sepa-
ration and presenting unknown inference in the prediction
samples. Slightly better results in the plasma samples analysis
are obtained by application of SWATLD calibration com-
pared to PARAFAC-ALS. The satisfactory recoveries were
obtained in all cases when several plasma samples were ana-
lyzed. This work demonstrated that the use of HPLC-DAD
coupled with second-order calibration algorithms is a pow-
erful tool to quantify overlapped chromatographic proﬁles
for complex analysis of drugs in plasma. At the same time,
the methodology involving PARAFAC and SWATLD did not
require as many calibration samples as the PLS models do
and, what is more, would allow the determination of any of
the vancomycin and cephalexin in the presence of unknown
interferences (second-order advantage) even if they were not
included in the model. Extremely important issues such as
reduction in the time of analysis and consequently costs and
amount of contaminant solvents should also be considered.
The ﬁgures of merit calculated for both PARAFAC and
SWATLD were very similar and the results should be con-
sidered satisfactory based on the complexity of the samples
analyzed. They are acceptable for some real applications,
such as pharmacokinetic investigations in patients.
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